vs
美国运通（AXP）与Verastem, Inc.（VSTM）财务数据对比。点击上方公司名可切换其他公司
美国运通的季度营收约是Verastem, Inc.的1.7倍（$18.9M vs $11.2M），美国运通净利率更高（15.7% vs -876.3%，领先892.1%）
美国运通是全球知名的支付服务提供商，主营签账卡、信用卡产品及旅行相关服务，下设全球消费者服务、全球商业服务、全球商户与网络服务三大业务板块，还提供支付融资、网络服务、应付账款费用管理、旅行生活服务等多元解决方案。
Verastem, Inc.以Verastem Oncology品牌开展业务，是一家总部位于美国马萨诸塞州波士顿的制药企业，专注于开发抗癌治疗药物，该公司成立于波士顿，同时是纳斯达克生物技术指数成分股之一。
AXP vs VSTM — 直观对比
营收规模更大
AXP
是对方的1.7倍
$11.2M
净利率更高
AXP
高出892.1%
-876.3%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.9M | $11.2M |
| 净利润 | $3.0M | $-98.5M |
| 毛利率 | — | — |
| 营业利润率 | — | -362.2% |
| 净利率 | 15.7% | -876.3% |
| 营收同比 | 11.4% | — |
| 净利润同比 | 15.0% | -311.1% |
| 每股收益（稀释后） | — | $-1.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXPVSTM
| Q1 26 | $18.9M | — | ||
| Q4 25 | $10.9B | — | ||
| Q3 25 | $10.4B | $11.2M | ||
| Q2 25 | $10.3B | $2.1M | ||
| Q1 25 | $9.6B | — | ||
| Q4 24 | $10.0B | — | ||
| Q3 24 | $9.7B | $0 | ||
| Q2 24 | $9.8B | $10.0M |
净利润AXPVSTM
| Q1 26 | $3.0M | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.9B | $-98.5M | ||
| Q2 25 | $2.9B | $-25.9M | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.2B | — | ||
| Q3 24 | $2.5B | $-24.0M | ||
| Q2 24 | $3.0B | $-8.3M |
营业利润率AXPVSTM
| Q1 26 | — | — | ||
| Q4 25 | 28.2% | — | ||
| Q3 25 | 36.7% | -362.2% | ||
| Q2 25 | 34.4% | -2047.9% | ||
| Q1 25 | 34.6% | — | ||
| Q4 24 | 27.7% | — | ||
| Q3 24 | 33.0% | — | ||
| Q2 24 | 38.6% | -182.8% |
净利率AXPVSTM
| Q1 26 | 15.7% | — | ||
| Q4 25 | 22.5% | — | ||
| Q3 25 | 27.9% | -876.3% | ||
| Q2 25 | 28.0% | -1213.6% | ||
| Q1 25 | 26.8% | — | ||
| Q4 24 | 21.8% | — | ||
| Q3 24 | 25.8% | — | ||
| Q2 24 | 30.7% | -82.6% |
每股收益（稀释后）AXPVSTM
| Q1 26 | — | — | ||
| Q4 25 | $3.52 | — | ||
| Q3 25 | $4.14 | $-1.35 | ||
| Q2 25 | $4.08 | $-0.62 | ||
| Q1 25 | $3.64 | — | ||
| Q4 24 | $3.04 | — | ||
| Q3 24 | $3.49 | $-0.60 | ||
| Q2 24 | $4.15 | $-0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $137.7M |
| 总债务越低越好 | $60.4M | — |
| 股东权益账面价值 | $34.0M | $-15.5M |
| 总资产 | $308.9M | $176.9M |
| 负债/权益比越低杠杆越低 | 1.78× | — |
8季度趋势，按日历期对齐
现金及短期投资AXPVSTM
| Q1 26 | — | — | ||
| Q4 25 | $742.0M | — | ||
| Q3 25 | $1.3B | $137.7M | ||
| Q2 25 | $197.0M | $164.3M | ||
| Q1 25 | $261.0M | — | ||
| Q4 24 | $221.0M | — | ||
| Q3 24 | $120.0M | $113.2M | ||
| Q2 24 | $188.0M | $83.4M |
总债务AXPVSTM
| Q1 26 | $60.4M | — | ||
| Q4 25 | $56.4B | — | ||
| Q3 25 | $57.8B | — | ||
| Q2 25 | $58.2B | — | ||
| Q1 25 | $51.2B | — | ||
| Q4 24 | $49.7B | — | ||
| Q3 24 | $53.5B | $40.5M | ||
| Q2 24 | $51.5B | $40.3M |
股东权益AXPVSTM
| Q1 26 | $34.0M | — | ||
| Q4 25 | $33.5B | — | ||
| Q3 25 | $32.4B | $-15.5M | ||
| Q2 25 | $32.3B | $36.1M | ||
| Q1 25 | $31.2B | — | ||
| Q4 24 | $30.3B | — | ||
| Q3 24 | $29.7B | $11.1M | ||
| Q2 24 | $29.5B | $18.9M |
总资产AXPVSTM
| Q1 26 | $308.9M | — | ||
| Q4 25 | $300.1B | — | ||
| Q3 25 | $297.6B | $176.9M | ||
| Q2 25 | $295.6B | $196.3M | ||
| Q1 25 | $282.2B | — | ||
| Q4 24 | $271.5B | — | ||
| Q3 24 | $271.0B | $126.4M | ||
| Q2 24 | $272.2B | $105.7M |
负债/权益比AXPVSTM
| Q1 26 | 1.78× | — | ||
| Q4 25 | 1.68× | — | ||
| Q3 25 | 1.78× | — | ||
| Q2 25 | 1.80× | — | ||
| Q1 25 | 1.64× | — | ||
| Q4 24 | 1.64× | — | ||
| Q3 24 | 1.80× | 3.66× | ||
| Q2 24 | 1.74× | 2.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-36.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AXPVSTM
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | — | ||
| Q3 25 | $6.2B | $-36.2M | ||
| Q2 25 | $4.4B | $-32.7M | ||
| Q1 25 | $4.8B | — | ||
| Q4 24 | $5.8B | — | ||
| Q3 24 | $-1.8B | $-23.8M | ||
| Q2 24 | $4.5B | $-27.6M |
自由现金流AXPVSTM
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | — | ||
| Q3 25 | $5.6B | — | ||
| Q2 25 | $3.7B | — | ||
| Q1 25 | $4.3B | — | ||
| Q4 24 | $5.3B | — | ||
| Q3 24 | $-2.3B | — | ||
| Q2 24 | $4.0B | $-27.6M |
自由现金流率AXPVSTM
| Q1 26 | — | — | ||
| Q4 25 | 21.4% | — | ||
| Q3 25 | 53.6% | — | ||
| Q2 25 | 36.3% | — | ||
| Q1 25 | 45.0% | — | ||
| Q4 24 | 53.1% | — | ||
| Q3 24 | -23.3% | — | ||
| Q2 24 | 40.4% | -275.8% |
资本支出强度AXPVSTM
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | — | ||
| Q3 25 | 6.3% | — | ||
| Q2 25 | 6.0% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 5.8% | 0.1% |
现金转化率AXPVSTM
| Q1 26 | — | — | ||
| Q4 25 | 1.25× | — | ||
| Q3 25 | 2.15× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 1.84× | — | ||
| Q4 24 | 2.66× | — | ||
| Q3 24 | -0.72× | — | ||
| Q2 24 | 1.50× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXP
| Discount revenue | $9.5M | 50% |
| Other | $8.9M | 47% |
| Deposits with banks and other | $512.0K | 3% |
VSTM
暂无分部数据
